126 related articles for article (PubMed ID: 36592736)
1. Palmitic acid-modified human serum albumin paclitaxel nanoparticles targeting tumor and macrophages against breast cancer.
Xiang L; Fang C; Feng J; Tan Y; Wu Q; Zhou X; Li J; Gong T
Eur J Pharm Biopharm; 2023 Feb; 183():132-141. PubMed ID: 36592736
[TBL] [Abstract][Full Text] [Related]
2. Dual-Targeting of Tumor Cells and Tumor-Associated Macrophages by Palmitic Acid Modified Albumin Nanoparticles for Antitumor and Antimetastasis Therapy.
Feng J; Xiang L; Fang C; Tan Y; Li Y; Gong T; Wu Q; Gong T; Zhang Z
ACS Appl Mater Interfaces; 2022 Apr; 14(13):14887-14902. PubMed ID: 35344323
[TBL] [Abstract][Full Text] [Related]
3. Self-promoted Albumin-Based Nanoparticles for Combination Therapy against Metastatic Breast Cancer via a Hyperthermia-Induced "Platelet Bridge".
Zhao W; Li T; Long Y; Guo R; Sheng Q; Lu Z; Li M; Li J; Zang S; Zhang Z; He Q
ACS Appl Mater Interfaces; 2021 Jun; 13(22):25701-25714. PubMed ID: 34041901
[TBL] [Abstract][Full Text] [Related]
4. Biguanide-anchored albumin-based nanoplatform inhibits epithelial-mesenchymal transition and reduces the stemness phenotype for metastatic cancer therapy.
Jiang T; Wang J; Xie L; Zhou S; Huang Y; Chen Y; Gao X; Xiao W; Chen J
Acta Biomater; 2023 Nov; 171():565-579. PubMed ID: 37716479
[TBL] [Abstract][Full Text] [Related]
5. Enhanced performance of macrophage-encapsulated nanoparticle albumin-bound-paclitaxel in hypo-perfused cancer lesions.
Leonard F; Curtis LT; Yesantharao P; Tanei T; Alexander JF; Wu M; Lowengrub J; Liu X; Ferrari M; Yokoi K; Frieboes HB; Godin B
Nanoscale; 2016 Jul; 8(25):12544-52. PubMed ID: 26818212
[TBL] [Abstract][Full Text] [Related]
6. Redox-responsive paclitaxel-pentadecanoic acid conjugate encapsulated human serum albumin nanoparticles for cancer therapy.
Zhang Y; Wang J; Xing H; Liu C; Li X
Int J Pharm; 2023 Mar; 635():122761. PubMed ID: 36822341
[TBL] [Abstract][Full Text] [Related]
7. Biomimetic Human Serum Albumin Nanoparticle for Efficiently Targeting Therapy to Metastatic Breast Cancers.
Liu L; Bi Y; Zhou M; Chen X; He X; Zhang Y; Sun T; Ruan C; Chen Q; Wang H; Jiang C
ACS Appl Mater Interfaces; 2017 Mar; 9(8):7424-7435. PubMed ID: 28150932
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel-loaded biodegradable ROS-sensitive nanoparticles for cancer therapy.
Pandya AD; Jäger E; Bagheri Fam S; Höcherl A; Jäger A; Sincari V; Nyström B; Štěpánek P; Skotland T; Sandvig K; Hrubý M; Mælandsmo GM
Int J Nanomedicine; 2019; 14():6269-6285. PubMed ID: 31496685
[TBL] [Abstract][Full Text] [Related]
9. Radionuclide I-131 Labeled Albumin-Paclitaxel Nanoparticles for Synergistic Combined Chemo-radioisotope Therapy of Cancer.
Tian L; Chen Q; Yi X; Wang G; Chen J; Ning P; Yang K; Liu Z
Theranostics; 2017; 7(3):614-623. PubMed ID: 28255354
[TBL] [Abstract][Full Text] [Related]
10. Redirecting Transport of Nanoparticle Albumin-Bound Paclitaxel to Macrophages Enhances Therapeutic Efficacy against Liver Metastases.
Tanei T; Leonard F; Liu X; Alexander JF; Saito Y; Ferrari M; Godin B; Yokoi K
Cancer Res; 2016 Jan; 76(2):429-39. PubMed ID: 26744528
[TBL] [Abstract][Full Text] [Related]
11. Substance P-modified human serum albumin nanoparticles loaded with paclitaxel for targeted therapy of glioma.
Ruan C; Liu L; Lu Y; Zhang Y; He X; Chen X; Zhang Y; Chen Q; Guo Q; Sun T; Jiang C
Acta Pharm Sin B; 2018 Jan; 8(1):85-96. PubMed ID: 29872625
[TBL] [Abstract][Full Text] [Related]
12. Exploring the synergistic behavior of paclitaxel and vorinostat upon co-loading in albumin nanoparticles for breast cancer management.
Abhang A; Katari O; Ghadi R; Chaudhari D; Jain S
Drug Deliv Transl Res; 2024 Feb; 14(2):510-523. PubMed ID: 37605040
[TBL] [Abstract][Full Text] [Related]
13. Smart Polymeric Nanoparticles with pH-Responsive and PEG-Detachable Properties (II): Co-Delivery of Paclitaxel and VEGF siRNA for Synergistic Breast Cancer Therapy in Mice.
Jin M; Hou Y; Quan X; Chen L; Gao Z; Huang W
Int J Nanomedicine; 2021; 16():5479-5494. PubMed ID: 34413645
[TBL] [Abstract][Full Text] [Related]
14. Facile one-pot formulation of TRAIL-embedded paclitaxel-bound albumin nanoparticles for the treatment of pancreatic cancer.
Min SY; Byeon HJ; Lee C; Seo J; Lee ES; Shin BS; Choi HG; Lee KC; Youn YS
Int J Pharm; 2015 Oct; 494(1):506-15. PubMed ID: 26315118
[TBL] [Abstract][Full Text] [Related]
15. Hyperthermal paclitaxel-bound albumin nanoparticles co-loaded with indocyanine green and hyaluronidase for treating pancreatic cancers.
Kim SS; Kim HK; Kim H; Lee WT; Lee ES; Oh KT; Choi HG; Youn YS
Arch Pharm Res; 2021 Feb; 44(2):182-193. PubMed ID: 32803685
[TBL] [Abstract][Full Text] [Related]
16. Novel polysaccharide building hybrid nanoparticles: remodelling TAMs to target ERα-positive breast cancer.
Guo C; Su Y; Wang B; Chen Q; Guo H; Kong M; Chen D
J Drug Target; 2022 Apr; 30(4):450-462. PubMed ID: 34927506
[TBL] [Abstract][Full Text] [Related]
17. Anti-tumor activity of paclitaxel through dual-targeting lipoprotein-mimicking nanocarrier.
Chen C; Hu H; Qiao M; Zhao X; Wang Y; Chen K; Chen D
J Drug Target; 2015 May; 23(4):311-22. PubMed ID: 25539074
[TBL] [Abstract][Full Text] [Related]
18. Free paclitaxel-loaded E-selectin binding peptide modified micelle self-assembled from hyaluronic acid-paclitaxel conjugate inhibit breast cancer metastasis in a murine model.
Han X; Dong X; Li J; Wang M; Luo L; Li Z; Lu X; He R; Xu R; Gong M
Int J Pharm; 2017 Aug; 528(1-2):33-46. PubMed ID: 28576551
[TBL] [Abstract][Full Text] [Related]
19. Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance.
Zhong P; Chen X; Guo R; Chen X; Chen Z; Wei C; Li Y; Wang W; Zhou Y; Qin L
Mol Pharm; 2020 Apr; 17(4):1114-1126. PubMed ID: 32176509
[TBL] [Abstract][Full Text] [Related]
20. Carfilzomib and Paclitaxel Co-Loaded Protein Nanoparticles an Effective Therapy Against Pancreatic Adenocarcinomas.
Cheng WT; Ho HO; Lin SY; Liu DZ; Chen LC; Sheu MT
Int J Nanomedicine; 2021; 16():6825-6841. PubMed ID: 34675510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
